Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 7/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asperuloside SCHEMBL308265 | 1.00 | STAT3 (0.42) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| Asperuloside SCHEMBL31666329 | 1.00 | STAT3 (0.42) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| Paederoside SCHEMBL422181 | 0.90 | STAT3 (0.41) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| Asperuloside SCHEMBL23495463 | 0.90 | PTPN1 (0.38) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| Deacetylasperuloside SCHEMBL29367563 | 0.87 | L3MBTL1 (0.53) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| SCHEMBL29426081 | 0.87 | L3MBTL1 (0.41) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| SCHEMBL29425770 | 0.85 | STAT3 (0.41) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| Asperuloside SCHEMBL7637719 | 0.85 | PTPN1 (0.38) | STAT3ELANEPTPN1 | |
| SCHEMBL422234 | 0.81 | ELANE (0.41) | STAT3L3MBTL1ELANEMAPTMEN1 | |
| SCHEMBL419331 | 0.81 | ELANE (0.41) | STAT3L3MBTL1ELANEMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021152-A1 | USE OF MALE FLOWER EXTRACT OF EUCOMMIA ULMOIDES OLIVER IN PREPARATION OF FOOD OR MEDICAMENT FOR RESISTING MUSCLE AGING | UNIV ZHEJIANG (CN) | 2026-01-22 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-3801062-B1 | FOOD SUPPLEMENT COMPRISING AN EXTRACT OF HALOPHYTE PLANTS | UNIV BRETAGNE OCCIDENTALE (FR) | 2025-07-30 | — | — | EP | claimed |
| US-20250205265-A1 | ASPERULOSIDE AS AN AGENT FOR IMPROVING VASCULAR AND METABOLIC FUNCTION IN OBESITY: ROLE OF NRF2 ACTIVATION | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-06-26 | — | — | US | claimed |
| CN-119350407-B | Template molecule, molecular imprinting material and application thereof in separation of iridoid glycoside compounds | 广州伽能生物科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119488451-A | Body acne-removing composition containing guaiacum extract and application thereof | 诺德溯源(广州)生物科技有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119453141-A | Breeding method for improving reproductive performance of sows | 广州朴成生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119138522-B | Compound feed for promoting reproduction of replacement gilts and preparation method and application thereof | 广州朴成农牧科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119355170-A | Quality detection method for oldenlandia diffusa formula granules for distinguishing counterfeit products and similar products | 长沙新林制药有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119350407-A | Template molecule, molecular imprinting material and application thereof in separation of iridoid glycoside compounds | 广州伽能生物科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-101496845-A | Hedyotis diffusa Willd. extract and method for separating and preparing the same | DALIAN CHEMICAL PHYSICS INST (CN) | 2009-08-05 | — | — | CN | claimed |
| CN-100457117-C | Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis | BIN LI (CN) | 2009-02-04 | — | — | CN | claimed |
| CN-100425243-C | Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis | BIN LI (CN) | 2008-10-15 | — | — | CN | claimed |
| CN-101156913-A | Application of fevervine iridoid glycosides and its preparation | LANLAN ZHOU (CN) | 2008-04-09 | — | — | CN | claimed |
| CN-101049360-A | Preparation of Chinese traditional medicine for treating gout disease, and application of extractive of Chinese feveruine | ZHOU LANLAN (CN) | 2007-10-10 | — | — | CN | claimed |
| CN-1915236-A | Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis | LI BIN (CN) | 2007-02-21 | — | — | CN | claimed |
| CN-1915235-A | Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis | LI BIN (CN) | 2007-02-21 | — | — | CN | claimed |
| US-7179287-B2 | Bioreactor mediated recellularization of natural and tissue engineered vascular grafts | BIOSCIENCE CONSULTANTS (US) | 2007-02-20 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-4410710-A | Conversion of iridoids to prostaglandins | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 1983-10-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021152-A1 | USE OF MALE FLOWER EXTRACT OF EUCOMMIA ULMOIDES OLIVER IN PREPARATION OF FOOD OR MEDICAMENT FOR RESISTING MUSCLE AGING | FIS1, OPA1, TFAM | STAT3 1806/4885L3MBTL1 2882/4885ELANE 1727/4885 |
| US-20250205265-A1 | ASPERULOSIDE AS AN AGENT FOR IMPROVING VASCULAR AND METABOLIC FUNCTION IN OBESITY: ROLE OF NRF2 ACTIVATION | KEAP1, HMOX1, NFE2L2 | STAT3 690/4885L3MBTL1 4752/4885ELANE 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.